Most parents approach a wedding as a bill. Save the money, write the checks, and move on. Investors

JNJ's Q2 Innovative Medicine results face scrutiny as Stelara biosimilar pressure offsets growth fro

Hearing aids restore conversations. Dental work restores smiles. Vision correction restores independ

The median U.S. household income is roughly $50,000 a year. It's also a common floor for a livable r

Bristol Myers Squibb focuses on specialized medicines in oncology and immunology, and shares sport a

It can provide some stability during volatile times.

Dow Jones medical giant Johnson & Johnson are breaking out past its latest buy point, while Iron Mou

Earned income demands your time. Passive income asks only that you stay invested.

The Bureau of Labor Statistics puts the median electrician at roughly $62,000 a year, while many exp

Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is

Retirement planning usually starts with fear: housing, healthcare, and outliving the portfolio. Yet

JNJ gets a positive CHMP opinion for Tecvayli in combination with Darzalex SC for treating relapsed/

LLY, ABBV, BIIB and JNJ hit new 52-week highs as biotech rallies, with company-specific pipeline, ap

Johnson & Johnson (JNJ) saw its shares surge in the last session with trading volume being higher th

AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market.

Financial independence rarely arrives with a parade. For many people, it shows up on a Tuesday morni

Utility bills are among the few expenses retirees never truly escape. The lights stay on, the water

Dividend investors love clean numbers. A $1 million portfolio yielding 5% generates $50,000 a year,

Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) CEO, Anthony Tennyson, talked with Proactive about p

Johnson and Johnson presents new IMAAVYÂ (nipocalimab-aahu) data at European Academy of Neurology (E

Healthcare stocks outperformed the broader market on Friday, with Eli Lilly (LLY), Johnson and Johns

Johnson & Johnson (NYSE:JNJ) today announced new data across 12 abstracts at the European Academ

Guggenheim analyst Vamil Divan raised his price target on Johnson & Johnson stock today. Upside is p

New analyses from the Phase 3 Vivacity-MG3 study support the impact of IMAAVY in anti-AChR+ a , anti

Bristol Myers Squibb maintains a robust biopharmaceutical portfolio focused on high-stakes oncology

College has become so expensive that many students and parents struggle to cover the cost on their o

Guggenheim analyst Vamil Divan maintains Johnson & Johnson (NYSE:JNJ) with a Buy and raises t

The Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) is the largest dividend-growth ETF in the U.S.

https://www.jnj.com/media-center/press-releases/chmp-recommendation-advances-johnson-johnsons-tecvay

Johnson & Johnson is on pace to generate roughly $100 billion in revenue in 2026. The company believ

Most drivers replace their vehicles the same way: make payments for a few years, trade the car in, t

Johnson & Johnson (JNJ) concluded the recent trading session at $244.88, signifying a +1.61% move fr

A $1,500 monthly car payment can buy a Porsche 911 lease, a Corvette Stingray note, or a Cadillac Es

I keep hitting the buy button on Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) because I have

Turning a $50,000 income stream into a $100,000 income stream sounds like it should require another

Most homeowners think of the mortgage as a bill that arrives every month and must be paid. Investors

IRVINE, Calif.--(BUSINESS WIRE)--Johnson & Johnson advances cardiac ablation technology in Europe wi

AbbVie will acquire Apogee for $10.9 billion, adding late-stage immunology and asthma assets to its

https://www.bloomberg.com/news/articles/2026-06-17/j-j-takes-a-pass-on-obesity-drugs-to-focus-effort

Investment includes new advanced manufacturing and packaging technologies and a new state-of-the-art

TALVEY plus DARZALEX FASPRO with or without pomalidomide showed progression-free survival of up to 8

Johnson & Johnson reports Phase 2/3 data showing IMAAVY improved hemoglobin levels in wAIHA pati

Expanded U.S. availability paired with new patient lifestyle quiz encourages informed decision-makin

Patients in the IMAAVY 30 mg/kg treatment groupa achieved statistically significant durable hemoglob

A Los Angeles jury has awarded $32 million to the family of a California woman who died from pleural

https://www.gov.uk/government/news/nipocalimab-imaavy-authorised-to-treat-adults-and-adolescents-wit

https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/

Laser Photonics Corp (NASDAQ:LASE) stock dips on Thursday. Read why traders are taking profits ahead

Johnson & Johnson (NYSE:JNJ) today announced nipocalimab met the primary endpoint of decreasing